Plain Language Summaries is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • How to
  • FAQs
  • Publications
  • Advisory Panel
    • Plain Language Advisors
    • Scientific Content Advisors
  • Supporters
  • Blog
  • About us
  • Contact Us

isavuconazole

17th Jul 2025

Plain language summary: how safe and effective isavuconazole is for treating serious fungal infections in children with weakened immune systems

Molds are types of fungus that can invade humans. It can cause a disease called invasive mold infection (IMI) and make people sick or cause death.
22nd Jan 2024

A plain language summary looking at isavuconazole to treat mold infections in Asia and the Western Pacific region

People with blood-related conditions have a higher chance of getting invasive fungal infections (IFIs). IFIs are severe fungal infections that can lead to death. Only a few medications, known as antifungals, exist that can be used to prevent IFIs, and sometimes they can cause very bad side effects. Isavuconazole is an antifungal which has been approved to treat IFIs, but it has not been approved to prevent IFIs. In this study, we reviewed published studies that looked at how well isavuconazole prevented IFIs in people who have a higher chance of getting IFIs
29th Aug 2023

Plain language summary: preventing fungal infections with isavuconazole in people with blood-related conditions

4th Aug 2022

Plain language summary: use of isavuconazole in Chinese patients with an invasive fungal disease

Copyright © 2026 · Plain Language Summaries · Terms and conditions · Privacy policy · Cookie policy